Filing Details
- Accession Number:
- 0001628280-24-048831
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-21 16:02:31
- Reporting Period:
- 2024-11-19
- Accepted Time:
- 2024-11-21 16:02:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1639438 | Cava Group Inc. | CAVA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1633916 | Karen Kochevar | C/O Cava Group, Inc. 14 Ridge Square Nw, Suite 500 Washington DC 20016 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-11-19 | 15,000 | $1.92 | 16,307 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-11-19 | 15,000 | $142.23 | 1,307 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (right to buy) | Disposition | 2024-11-19 | 15,000 | $0.00 | 15,000 | $1.92 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
17,878 | 2026-11-01 | No | 4 | M | Direct |
Footnotes
- Includes unvested restricted stock units.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.22 to $142.27, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- All of the shares subject to this option are fully vested and exercisable as of the date hereof.